Interesting study carried out by Tarbiat Modares University and Tehran University of Medical Sciences (TUMS)
on Liquid Biopsy using MagCore® automated system: Assessing the Diagnostic Value of Plasma-Free DNA in Prostate Cancer Screening

“cfDNA can be used as a noninvasive and a promising novel biomarker; therefore, it could be a robust tool for prognosis and diagnosis goals.”

Publication at the following Link